Huang Yikun, Nieh Mu-Ping, Chen Wilfred, Lei Yu
Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut, USA.
Department of Chemical and Biomolecular Engineering, University of Connecticut, Storrs, Connecticut, USA.
Biotechnol Bioeng. 2022 Jan;119(1):34-47. doi: 10.1002/bit.27965. Epub 2021 Nov 6.
Outer membrane vesicles (OMVs) are nanoscale spherical vesicles released from Gram-negative bacteria. The lipid bilayer membrane structure of OMVs consists of similar components as bacterial membrane and thus has attracted more and more attention in exploiting OMVs' bio-applications. Although the endotoxic lipopolysaccharide on natural OMVs may impose potential limits on their clinical applications, genetic modification can reduce their endotoxicity and decorate OMVs with multiple functional proteins. These genetically engineered OMVs have been employed in various fields including vaccination, drug delivery, cancer therapy, bioimaging, biosensing, and enzyme carrier. This review will first briefly introduce the background of OMVs followed by recent advances in functionalization and various applications of engineered OMVs with an emphasis on the working principles and their performance, and then discuss about the future trends of OMVs in biomedical applications.
外膜囊泡(OMVs)是革兰氏阴性细菌释放的纳米级球形囊泡。OMVs的脂质双分子层膜结构由与细菌膜相似的成分组成,因此在开发OMVs的生物应用方面越来越受到关注。尽管天然OMVs上的内毒素脂多糖可能会对其临床应用造成潜在限制,但基因改造可以降低其内毒素毒性,并使OMVs带有多种功能蛋白。这些基因工程OMVs已被应用于包括疫苗接种、药物递送、癌症治疗、生物成像、生物传感和酶载体等各个领域。本综述将首先简要介绍OMVs的背景,接着阐述工程化OMVs功能化及各种应用的最新进展,重点介绍其工作原理和性能,然后讨论OMVs在生物医学应用中的未来趋势。